These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6138246)

  • 21. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.
    Reisine T
    J Pharmacol Exp Ther; 1984 Apr; 229(1):14-20. PubMed ID: 6142943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin receptors are biologically active before they are inserted into the plasma membrane.
    Steiner C; Dahl R; Sherman N; Trowbridge M; Vatter A; Robbins R; Draznin B
    Endocrinology; 1986 Feb; 118(2):766-72. PubMed ID: 2867891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs.
    Reubi JC; Perrin M; Rivier J; Vale W
    Regul Pept; 1982 Aug; 4(3):141-6. PubMed ID: 6127756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
    Raynor K; Reisine T
    J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
    Thermos K; Reisine T
    Mol Pharmacol; 1988 Apr; 33(4):370-7. PubMed ID: 2895889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.
    Presky DH; Schonbrunn A
    J Biol Chem; 1988 Jan; 263(2):714-21. PubMed ID: 2891702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
    Reisine T; Guild S
    J Pharmacol Exp Ther; 1985 Dec; 235(3):551-7. PubMed ID: 2867203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of functional receptors for somatostatin in rat pituitary cells in culture.
    Schonbrunn A; Tashjian H
    J Biol Chem; 1978 Sep; 253(18):6473-83. PubMed ID: 210185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtypes of somatostatin receptors are expressed in the anterior pituitary cell line GH3.
    Raynor K; Reisine T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):110-6. PubMed ID: 8093718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors.
    Srikant CB; Patel YC
    Endocrinology; 1985 May; 116(5):1717-23. PubMed ID: 2859190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
    Heiman ML; Murphy WA; Coy DH
    Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
    Kashio Y; Chomczynski P; Downs TR; Frohman LA
    Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin.
    Goth MI; Lyons CE; Ellwood MR; Barrett JR; Thorner MO
    Endocrinology; 1996 Jan; 137(1):274-80. PubMed ID: 8536623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
    Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
    Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.